Quick Takeaways
- Squadron Capital Management LLC filed SCHEDULE 13G/A for Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW).
- Disclosed ownership: 8.4%.
- Date of event: 30 Sep 2025.
Squadron Capital Management LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW)
- Filing Manager
- Squadron Capital Management LLC
- Reporting Manager
- Squadron Capital Management LLC
- Symbol
- TRAW
- Shares outstanding
- 7,035,714 shares
- Disclosed Ownership
- 591,000 shares
- Ownership
- 8.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 14:29:27 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 19 Sep 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Squadron Capital Management LLC disclosed 8.4% ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 19 Sep 2025.
- Current filing was accepted on 14 Nov 2025, 14:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Squadron Master Fund LP | 7.4% | 523,359 | 0 | 523,359 | /s/ Matthew Sesterhenn | Partner, Squadron Partners LLC, its General Partner | |
| Squadron Capital Management LLC | 8.4% | 591,000 | 0 | 591,000 | /s/ Matthew Sesterhenn | Partner | |
| Matthew Sesterhenn | 8.4% | 591,000 | 0 | 591,000 | /s/ Matthew Sesterhenn | Matthew Sesterhenn | |
| William Blank | 8.4% | 591,000 | 0 | 591,000 | /s/ William Blank | William Blank |